In this week's #AskDrDurie video, IMF Chairman Dr. Brian Durie discusses how intravenous immunoglobulin is being used as a treatment option for multiple myeloma.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.